Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne, Fitzroy, Vic, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, Vic, Australia; and PathWest Department of Diagnostic Genomics, QEII Medical Centre, Nedlands, WA, Australia.
Evol Med Public Health. 2013 Jan;2013(1):225-40. doi: 10.1093/emph/eot020. Epub 2013 Oct 1.
The human erythroleukaemia (HEL) cell line has a highly rearranged genome. We matched whole chromosome analysis with cytogenomic microarray data to build a detailed description of these rearrangements.
We used a combination of single nucleotide polymorphism array and multiple fluorescence in situ hybridization approaches, and compared our array data with publicly available data for different sublines of HEL. B allele frequencies revealed the fate of each homologue for most chromosomes.
At least two instances of the breakage-fusion-bridge cycle appear to have facilitated amplification of oncogenes and deletion of tumour suppressor genes. Because our study included centromere identification, we found that some abnormal chromosomes had centromeres that did not match the identity of the rest of the chromosome.
This study highlights the variety of complementary methods required to understand remodelling of the genome in cancer and uncover some of the mechanisms involved. We present evidence of centromere capture as a means of preserving broken chromosome segments. Testing for another highly repetitive DNA region, the nucleolus organizer region, helped identify the steps involved in chromosome 9 copy number aberrations. Increased use of techniques for identifying centromeres and other repetitive DNA regions will add to our understanding of genome remodelling and evolution. The pattern of chromosome 20 aberration in HEL supports an association of 20q11.21 amplification with erythroleukaemia (acute myeloid leukaemia subtype M6) in the context of 20q12 deletion. The differences between the karyotypes in different HEL sublines highlight the constantly evolving genomes of cultured cell lines.
人红白血病(HEL)细胞系的基因组高度重排。我们将全染色体分析与细胞基因组微阵列数据匹配,以构建这些重排的详细描述。
我们使用单核苷酸多态性阵列和多重荧光原位杂交方法相结合,将我们的阵列数据与不同 HEL 亚系的公开可用数据进行比较。B 等位基因频率揭示了大多数染色体同源物的命运。
至少有两个断裂-融合-桥循环的实例似乎促进了癌基因的扩增和肿瘤抑制基因的缺失。由于我们的研究包括着丝粒鉴定,我们发现一些异常染色体的着丝粒与染色体其余部分的身份不匹配。
本研究强调了理解癌症中基因组重排所需的各种互补方法,并揭示了一些涉及的机制。我们提出了作为保留断裂染色体片段的手段的着丝粒捕获的证据。测试另一个高度重复的 DNA 区域——核仁组织区域,有助于确定染色体 9 拷贝数异常涉及的步骤。增加鉴定着丝粒和其他重复 DNA 区域的技术的使用将有助于我们理解基因组重排和进化。HEL 中染色体 20 异常的模式支持 20q11.21 扩增与 20q12 缺失相关联的急性髓性白血病(M6 亚型)。不同 HEL 亚系的核型差异突出了培养细胞系不断进化的基因组。